楚天科技(300358.SZ)正籌劃收購德國Romaco公司的股權 明起停牌
格隆匯12月9日丨楚天科技(300358.SZ)公佈,公司正在籌劃發行股份、可轉換公司債券及支付現金購買資產並募集配套資金,募集配套資金方式包括但不限於非公開發行股票或發行可轉換公司債券,此次籌劃為購買長沙楚天投資集團有限公司(“楚天投資”)、湖南澎湃股權投資管理服務有限責任公司(“澎湃投資”)持有的楚天資產管理(長沙)有限公司(“楚天資管”)股權即購買其間接持有德國Romaco公司的股權,此次交易相關審計、評估事項仍在進行當中,預計構成重大資產重組及重大關聯交易。
Romaco總部位於德國巴登符騰堡州卡爾斯魯厄市,是世界頂級醫藥包裝機械及自動化方案提供商,屬於醫藥裝備行業世界一流品牌,主要提供的產品及服務是固體類藥物的生產裝備,包括粉末分裝解決方案、泡罩包裝解決方案、條形包裝解決方案、藥片擠壓解決方案、藥片/膠囊罐裝設備等。Romaco的產品已銷往180個國家,與Bayer, GSK等多家世界大型製藥公司一直保持着穩定持續的合作關係,在行業內積累了豐富的優質客户資源。
因有關事項尚存不確定性,為維護投資者利益,避免對公司股價造成重大影響,根據深圳證券交易所的相關規定,經公司申請,公司股票自2019年12月10日上午開市起停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.